Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies
Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.
Authors
- Shuyu Zhang (ORCID: https://orcid.org/0009-0000-9465-7801)
- Qionghui Zhan (ORCID: https://orcid.org/0009-0001-6834-6417)
- Xuefang Shen
- Ying Li
Institutions
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/ijms272210274
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities